Interestingly, in a preclinical melanoma model, Bender et al. found that the probiotic-released AhR ligand indole-3-aldehyde promoted anti-tumor immunity via interferon-γ-producing CD8+ T cells and improved ICI efficacy [145]. Here, CD8A is linked to melanoma.